JRCT ID: jRCT2080220556
Registered date:15/05/2008
Basic Information
Recruitment status | |
---|---|
Health condition(s) or Problem(s) studied | Patients scheduled to undergo MRCP |
Date of first enrollment | 15/05/2008 |
Target sample size | |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : OMR-12200 INN of investigational material : Therapeutic category code : 729 Other diagnostic agents (except extracorporeal diagnostic medicines) Dosage and Administration for Investigational material : Oral |
Outcome(s)
Primary Outcome | Efficacy, Safety |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | >= 20age old |
---|---|
Age maximum | <= 79age old |
Gender | Both |
Include criteria | Patients age 20 years or older and less than 80 years (at time of informed consent) |
Exclude criteria |
Related Information
Primary Sponsor | Otsuka Pharmaceutical Co., Ltd. |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | JapicCTI-080578 |
Contact
Public contact | |
Name | |
Address | 03-6361-7314 |
Telephone | |
Affiliation | Otsuka Pharmaceutical Co., Ltd. |
Scientific contact | |
Name | |
Address | |
Telephone | |
Affiliation |